BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 21151200)

  • 21. Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.
    Lindblom R; Higgins G; Coughlan M; de Haan JB
    Rev Diabet Stud; 2015; 12(1-2):134-56. PubMed ID: 26676666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress.
    Rosas-Martínez L; Rodríguez-Muñoz R; Namorado-Tonix MDC; Missirlis F; Del Valle-Mondragón L; Sánchez-Mendoza A; Reyes-Sánchez JL; Cervantes-Pérez LG
    Life Sci; 2021 Mar; 268():119003. PubMed ID: 33417957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and advanced glycation in diabetic nephropathy.
    Coughlan MT; Mibus AL; Forbes JM
    Ann N Y Acad Sci; 2008 Apr; 1126():190-3. PubMed ID: 18448815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of treatment that target protective mechanisms against diabetic nephropathy.
    Mima A; Qi W; King GL
    Semin Nephrol; 2012 Sep; 32(5):471-8. PubMed ID: 23062988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of AGEs in diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic nephropathy.
    Boner G; Cooper ME
    Diabetes Technol Ther; 1999; 1(4):489-96. PubMed ID: 11474836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allium tuberosum alleviates diabetic nephropathy by supressing hyperglycemia-induced oxidative stress and inflammation in high fat diet/streptozotocin treated rats.
    Ni Z; Guo L; Liu F; Olatunji OJ; Yin M
    Biomed Pharmacother; 2019 Apr; 112():108678. PubMed ID: 30784905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapeutic targets for diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):83-92. PubMed ID: 17584148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactive oxygen species and oxidative stress.
    Noh H; Ha H
    Contrib Nephrol; 2011; 170():102-112. PubMed ID: 21659763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy.
    Arora MK; Singh UK
    Curr Drug Targets; 2014 May; 15(5):531-8. PubMed ID: 24655140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications.
    Goycheva P; Petkova-Parlapanska K; Georgieva E; Karamalakova Y; Nikolova G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy.
    Arellano Buendía AS; Tostado González M; Sánchez Reyes O; García Arroyo FE; Argüello García R; Tapia E; Sánchez Lozada LG; Osorio Alonso H
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Miyata T; Yamamoto M; Izuhara Y
    Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrion and its role in diabetic nephropathy.
    Khoshjou F; Dadras F
    Iran J Kidney Dis; 2014 Sep; 8(5):355-8. PubMed ID: 25194400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
    Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
    Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future of interventions in diabetic nephropathy: antioxidants.
    Ha H; Kim KH
    Perit Dial Int; 1999; 19 Suppl 2():S228-33. PubMed ID: 10406524
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy.
    Yang J; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():816400. PubMed ID: 35692405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.